ADAG
Adagene Inc.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 4/17/2026 | View on SEC |
| 424B5 | 4/2/2026 | View on SEC |
| 6-K | 4/2/2026 | View on SEC |
| 424B5 | 4/2/2026 | View on SEC |
| 6-K | 4/2/2026 | View on SEC |
| 6-K | 4/1/2026 | View on SEC |
| 20-F | 4/1/2026 | View on SEC |
| SCHEDULE 13G | 3/18/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
| 3 | 3/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ADAG |
| Company Name | Adagene Inc. |
| CIK | 1818838 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 86-512-87773632 |